Synthesis and biological evaluation of retinoid-chalcones as inhibitors of colon cancer cell growth

Published on Wednesday, 10 September 2014


Based on the observed anticancer activity of chalcones and retinoids, a novel class of retinoid-chalcone hybrids was designed and synthesized.

As part of our ongoing studies to discover natural product based anticancer compounds, the retinoid-chalcone hybrids were tested against the colon cancer cell line HT-29.

Retinoid like moiety was introduced through Friedel-Crafts alkylation of toluene.

Among the synthesized compounds, the cyano derivative (E)-3-(3-oxo-3-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-enyl)benzonitrile 8 showed submicromolar inhibitory activity with an IC(50) of 0.66 μM.



Supplementary Data



About this publication.


See also All-Trans-Retinoic Acid (ATRA - analogues and/or derivatives).